Company A, which is based outside of Japan, had no operations in Japan before partnering with CoreMed. With CoreMed acting as their local team for regulatory affairs, we worked collaboratively towards gaining approval. As a result of their collaborative efforts, Company A has now become a Marketing Approval Holder (MAH) in Japan and is in the process of expanding its organization.